Lexeo Therapeutics on Tuesday said the Food and Drug Administration appears willing to review, and potentially approve, its experimental rare disease gene therapy more quickly than previously ...
Holy Cross and New England Conservatory (NEC) have announced a new partnership creating an accelerated pathway for Holy Cross students to earn a Bachelor of Arts from Holy Cross and a Master of Music ...